New players in the 5-HT receptor field: genes and knockouts.

[1]  H. Kao,et al.  The 5‐HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. , 1995, The EMBO journal.

[2]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[3]  S. Rees,et al.  Cloning and characterisation of the human 5‐HT5A serotonin receptor , 1994, FEBS letters.

[4]  R. Hen,et al.  5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates , 1994, Neurochemistry International.

[5]  R Hen,et al.  Enhanced aggressive behavior in mice lacking 5-HT1B receptor. , 1994, Science.

[6]  A. Tsou,et al.  Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl Cyclase , 1994, Journal of neurochemistry.

[7]  M. Caron,et al.  Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine. , 1994, Molecular pharmacology.

[8]  H. Saito,et al.  Inhibition by 5‐HT7 receptor stimulation of GABAA receptor‐activated current in cultured rat suprachiasmatic neurones. , 1994, The Journal of physiology.

[9]  K. Rajewsky,et al.  Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. , 1994, Science.

[10]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[11]  R. Rothman,et al.  Treatment with antisense oligodeoxynucleotide to the opioid δ receptor selectively inhibits δ2-agonist antinociception , 1994 .

[12]  G. Pasternak,et al.  Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor , 1994, Neuron.

[13]  P. Molinoff,et al.  Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[14]  D. Sibley,et al.  Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[15]  B. Weiss,et al.  In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. , 1994, The Journal of pharmacology and experimental therapeutics.

[16]  R. Hen,et al.  The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals , 1994, Neuroscience.

[17]  T. Branchek,et al.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.

[18]  N. Morgan,et al.  Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080 , 1993, British journal of pharmacology.

[19]  J. Takeda,et al.  Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase. , 1993, Molecular pharmacology.

[20]  D. Clarke,et al.  The 5‐HT4 Receptor , 1993, Medicinal research reviews.

[21]  P. Seeburg,et al.  Cloning and characterization of the rat 5‐HT5B receptor , 1993, FEBS letters.

[22]  J. Bockaert,et al.  [3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. , 1993, Neuroreport.

[23]  Laurent Journot,et al.  Differential signal transduction by five splice variants of the PACAP receptor , 1993, Nature.

[24]  S. Narumiya,et al.  Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity , 1993, Nature.

[25]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[26]  D. Sibley,et al.  Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.

[27]  J. Plassat,et al.  Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. , 1993, Molecular pharmacology.

[28]  Gavin Kilpatrick,et al.  Development of a radioligand binding assay for 5‐HT4 receptors in guinea‐pig and rat brain , 1993, British journal of pharmacology.

[29]  W. Meyerhof,et al.  A novel rat serotonin receptor: primary structure, pharmacology, and expression pattern in distinct brain regions. , 1993, DNA and cell biology.

[30]  J. Schwartz,et al.  A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. , 1993, Biochemical and biophysical research communications.

[31]  M. Colado,et al.  Molecular mechanisms of pain: Serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons , 1993, Neuron.

[32]  H. Heller,et al.  Serotonin and the Mammalian Circadian System: I. In Vitro Phase Shifts by Serotonergic Agonists and Antagonists , 1993, Journal of biological rhythms.

[33]  D. Sibley,et al.  Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. , 1993, Molecular pharmacology.

[34]  M. Mattei,et al.  Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. , 1993, Molecular pharmacology.

[35]  G. Koob,et al.  Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. , 1993, Science.

[36]  U. Boschert,et al.  The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. , 1992, The EMBO journal.

[37]  M. Hamon,et al.  Central serotonin1A receptors: Respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain , 1991, Neurochemistry International.

[38]  T. Halazonetis,et al.  Familial holoprosencephaly associated with a translocation breakpoint at chromosomal position 7q36. , 1991, American journal of medical genetics.

[39]  J. Palacios,et al.  The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution , 1990, Neuroscience.

[40]  Mario R. Capecchi,et al.  Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development , 1990, Nature.

[41]  S. Peroutka,et al.  d-Lysergic acid diethylamide differentially affects the dual actions of 5-hydroxytryptamine on cortical neurons , 1990, Neuropharmacology.

[42]  M. Pompeiano,et al.  Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites , 1990, Brain Research.

[43]  T. Mansour,et al.  Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor. , 1990, Molecular pharmacology.

[44]  P. Barone,et al.  5‐HYDROXYTRYPTAMINE STIMULATES TWO DISTINCT ADENYLATE CYCLASE ACTIVITIES IN RAT BRAIN: HIGH‐AFFINITY ACTIVATION IS RELATED TO A 5‐HT1 SUBTYPE DIFFERENT FROM 5‐HT1A, 5‐HT1B, AND 5‐HT1C , 1988, Fundamental & clinical pharmacology.

[45]  W. Feniuk,et al.  5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. , 1986, Life sciences.

[46]  M. Perren,et al.  5‐Carboxamidotryptamine is a selective agonist at 5‐hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats , 1986, British journal of pharmacology.

[47]  H. Weinstein,et al.  Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone. , 1985, European journal of pharmacology.

[48]  R. Cone,et al.  Cloning and expression of a 5HT7 receptor from Xenopus laevis. , 1995, Receptors & channels.

[49]  A. Sleight,et al.  Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. , 1995, Molecular pharmacology.

[50]  E. Tolosa,et al.  Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species. , 1994, Brain research. Molecular brain research.

[51]  J. Fozard,et al.  The 5-HT4 receptor: a place in the sun. , 1992, Trends in pharmacological sciences.

[52]  S. Peroutka.  Serotonin receptor subtypes : basic and clinical aspects , 1991 .